Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human Study to Access Feasibility and Safety of the Optimum Aortic Valve Implant

NCT04076150 is registered in ClinicalTrials.gov with Thubrikar Aortic Valve, Inc. as lead sponsor.

NCT NCT04076150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04076150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human Study to Access Feasibility and Safety of the Optimum Aortic Valve Implant
Lead sponsor
Thubrikar Aortic Valve, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
May 18, 2022
Completion date
May 18, 2027
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe aortic stenosis